Exscientia plc (EXAI)
NASDAQ: EXAI · IEX Real-Time Price · USD
3.990
-0.140 (-3.39%)
At close: Apr 25, 2024, 4:00 PM
3.960
-0.030 (-0.75%)
After-hours: Apr 25, 2024, 7:14 PM EDT
Exscientia Market Cap
Exscientia has a market cap or net worth of $501.55 million as of April 25, 2024. Its market cap has decreased by -22.90% in one year.
Market Cap
501.55M
Enterprise Value
71.07M
1-Year Change
-22.90%
Ranking
Category
Stock Price
$3.99
Market Cap Chart
Since the IPO on October 1, 2021, Exscientia's market cap has decreased from $2.61B to $501.55M, a decrease of -80.79%. That is a compound annual growth rate of -47.44%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 24, 2024 | 519.20M | -5.70% |
Apr 23, 2024 | 550.60M | 3.07% |
Apr 22, 2024 | 534.20M | 0.23% |
Apr 19, 2024 | 533.00M | -2.75% |
Apr 18, 2024 | 548.10M | 0.94% |
Apr 17, 2024 | 543.00M | 1.65% |
Apr 16, 2024 | 534.20M | -2.54% |
Apr 15, 2024 | 548.10M | -6.32% |
Apr 12, 2024 | 585.10M | -5.20% |
Apr 11, 2024 | 617.20M | 3.26% |
Apr 10, 2024 | 597.70M | -3.36% |
Apr 9, 2024 | 618.50M | -0.90% |
Apr 8, 2024 | 624.10M | 2.58% |
Apr 5, 2024 | 608.40M | -2.61% |
Apr 4, 2024 | 624.70M | 1.63% |
Apr 3, 2024 | 614.70M | -6.05% |
Apr 2, 2024 | 654.30M | -4.15% |
Apr 1, 2024 | 682.60M | -5.06% |
Mar 28, 2024 | 719.00M | -1.05% |
Mar 27, 2024 | 726.60M | 0.71% |
Mar 26, 2024 | 721.50M | -3.37% |
Mar 25, 2024 | 746.70M | -1.98% |
Mar 22, 2024 | 761.80M | -1.30% |
Mar 21, 2024 | 771.80M | -9.64% |
Mar 20, 2024 | 854.10M | 10.11% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Verve Therapeutics | 542.77M |
Castle Biosciences | 538.29M |
Astria Therapeutics | 538.05M |
Jin Medical International | 536.96M |
IRadimed | 536.40M |
Celcuity | 534.15M |
ArriVent BioPharma | 532.55M |
Altimmune | 529.59M |